Katy Koski is a partner in Foley’s Commercial Litigation Practice Group, focusing on product liability litigation. Foley provides clients with tailored solutions to managing and defending their products from individual and class action attacks. Foley brings litigation and dispute resolution experience to bear across modern and emerging product sectors. In this video, Katy discusses how Foley can tailor a litigation strategy to help achieve your business goals. Our breadth of industry experience allows us to present a team of lawyers best suited to your needs.
Key Takeaways
- Foley lawyers can provide clients with tailored solutions to managing and defending their products from individual and class action attacks.
- Our litigation and dispute resolution expertise in modern and emerging product sectors includes pharmaceuticals and medical devices, automotive and other automotive vehicles, industrial equipment, food products, and health and beauty products.
- Our product liability lawyers counsel you in litigation avoidance, early resolution, and vigorous defense in traditional courtroom settings, as well as alternative dispute forums
- Upon receiving notice of a claim, we can assist you in evaluating several key issues.
- The product itself. Is this a marquee product line for your company or a legacy product no longer on the market and driving your profits.
- The potential for additional claims. Is this a case where it may be a single one-off plaintiff, or could it develop into mass tort litigation or even class actions?
- Defenses. Are there broad ranging defenses such as federal preemption or statutes of limitation that will allow for early legal dismissal?
- Where the claims are brought in the mass tort or class action context, Foley is also suited to service as outside coordinating council, allowing for coordinated strategy and efficiencies, relying on our industry expertise, the geographic breadth of our lawyers and Foley’s offices, and allowing for a rate structure that allows you to coordinate insured claims.
Author(s)
Related Insights
December 4, 2025
Foley Viewpoints
FDA Guidance on Biosimilars Highlights Glycosylation Profiling and Increases the Strategic Value of Patents Covering Antibodies Defined by Glycosylation
FDA’s September 2025 guidance requires detailed characterization of posttranslational modifications (PTMs), particularly glycosylation,…
December 3, 2025
Manufacturing Industry Advisor
Made in China: What the Automotive Industry Should Know About the Global Emergence of Chinese Manufacturing of Connected Vehicles Amid Increasing U.S. Restrictions
China’s automotive industry has gone global, in no small part due to technological advancements, cost advantages, and foreign investment through joint ventures, particularly in electric vehicle (“EV”) and connected vehicle technologies.
December 3, 2025
Foley In Fashion
How Tariffs Are Reshaping Holiday Shopping Trends for Fashion, Apparel & Beauty Brands
As the holiday rush approaches, tariffs have quickly become one of the most influential forces shaping retail strategies. A wave of updated import duties is driving up costs across apparel, accessories, cosmetics and beauty packaging – creating pressures many brands are already confronting as they prepare for peak retail months.
